Although there are reports suggesting that AKT activation can protect cells under glucose deprivation, regulation of this oncogenic pathway under glucose restriction has been shown to be sophisticated and specific to different cancer cells and backgrounds [39]. The gene discussed is AKT1; the disease is cancer.